Results 241 to 250 of about 2,507,641 (307)

Survival following sublobar resection after neoadjuvant therapy for T1N1-2M0 lung cancer. [PDF]

PLoS One
Reddington H, Emmerick I, Diaz Collante J, Maini A, Kanzaria R, Crawford A, Phillips W, Maxfield M, Uy K, Lou F.   +9 more
europepmc   +1 more source

Application of MR Cytometry in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparative Study

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background MR cytometry imaging is developed to characterize in vivo microstructures. Its clinical value in predicting pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) for breast cancer remains unknown. Purpose To implement MR cytometry to predict pCR for breast cancer and compare the performance of different ...
Jie Ding, Diwei Shi, Shiyun Sun, Jinlong Zheng, Wentao Yang, Caixia Fu, Dazhi Chen, Junzhong Xu, Hua Guo, Chao You, Yajia Gu   +10 more
wiley   +1 more source

Benefit-Hematotoxicity Stratification in Patients with Triple-Negative Breast Cancer Receiving Platinum-Based Neoadjuvant Therapy: A Multitask Deep Learning Study. [PDF]

Cancers (Basel)
Sun H, Zhou X, Liang J, Shi Y, Deng B, Guo Z, Su T, Guo B, Zhong L.   +8 more
europepmc   +1 more source

Comparison of Continuous‐Time Random Walk and Fractional Order Calculus Diffusion Models for Preoperative Breast Lesion Characterization: Diagnosis, Biomarker Prediction and Molecular Subtyping

Journal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT Background Accurate preoperative characterization of breast lesions is important for individualized management. The conventional monoexponential (Mono) model has limited ability to capture the complex microstructure of lesions. Non‐Gaussian diffusion models, including continuous‐time random walk (CTRW) and fractional‐order calculus (FROC), may
Yimeng Cao, Shaomin Li, Zhexuan Yang, Xueyan Liu, Shifang Tan, Tian Ren, Wenjia Wang, Haiyang Li, Xingzhi Chen, Xin Zhao, Meiying Cheng   +10 more
wiley   +1 more source

The Impact of Androgen Receptor Expression on Neoadjuvant Therapy in HER2-Positive Breast Cancer. [PDF]

Breast Cancer (Dove Med Press)
Tian C, Qiu J, Fan Y, Yu H, Liu S.
europepmc   +1 more source

Impact of Neoadjuvant Approach and Tumor Response on Survival in Pancreatic Adenocarcinoma

Journal of Surgical Oncology, EarlyView.
ABSTRACT Introduction Neoadjuvant therapy for pancreatic adenocarcinoma (PDAC) has evolved from single‐agent to multi‐agent approaches, largely informed by metastatic disease studies demonstrating improved survival; albeit at the price of increased toxicity. It remains unclear how response to varied neoadjuvant regimens impact survival. We hypothesized
Mohammed O. Suraju, Brian Longbottom, Jasmine A. Peterson, Terry Hayes, Kiers Brevik, Sean Y. Kim, Paolo Goffredo, Imran Hassan, Hassan Aziz, Carlos H. F. Chan   +9 more
wiley   +1 more source

Prognostic Impact of Tumor Regression and Downstaging After Neoadjuvant Therapy in Rectal Cancer. [PDF]

Iran J Pathol
Sanei MH, Hemati Z, Sanei B, Izadi A, Modares A, Sanei M.   +5 more
europepmc   +1 more source

Extended Versus Non‐Extended Lymphadenectomy in Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta‐Analysis

Journal of Surgical Oncology, EarlyView.
ABSTRACT Pelvic lymph node dissection is an essential component of radical cystectomy (RC) for bladder cancer (BC), but the optimal extent of lymphadenectomy remains uncertain. We conducted a systematic review and meta‐analysis to compare oncologic and perioperative outcomes between extended and non‐extended lymphadenectomy during RC for BC.
Maria Fernanda Dias Azevedo, Pedro Henrique Souza Brito, Lucas Kallas‐Silva, Bruno Liebl, Beatriz Taveira Constantinou, Bianca Caroline Benedicto, Lucas Paschoalino de Oliveira, Mauricio Dener Cordeiro, William Carlos Nahas, Walid Shabana, Walid Shahrour, Leopoldo Alves Ribeiro‐Filho, Caio Vinicius Suartz   +12 more
wiley   +1 more source

Basal cell subsets, as biomarker to predict the therapeutic effect of neoadjuvant therapy for esophageal carcinoma. [PDF]

J Cancer Res Clin Oncol
Xin X, Lu J, Zhang X, Zhang J, Li Y, Xu X, Li J, Gong L, Lu Q.   +8 more
europepmc   +1 more source

Transoral Robotic Surgery in Head and Neck Oncology: A Scoping Review of Evidence, Technological Advancements, and Future Trajectories

Journal of Surgical Oncology, EarlyView.
ABSTRACT Robotic surgery has transformed head and neck cancer (HNC) treatment. This scoping review synthesizes evidence on transoral robotic surgery (TORS), focusing on applications, limitations, and future directions. Following PRISMA‐ScR guidelines, this review used the PCC framework (Population: HNC patients; Concept: technological advancements ...
Anna Luíza Damaceno Araújo, Karthik N. Rao, Juan P. Rodrigo, Vincent Vander Poorten, Orlando Guntinas‐Lichius, Alfio Ferlito, Luiz Paulo Kowalski   +6 more
wiley   +1 more source